Importantly, this pattern of late-onset ALP pathology progression, e.g., AL/pa-AL increases, is consistent with our findings from HD human brains (Berg et al., 2024) where enlarged CTSD-positive AL accumulate and cluster in affected neuronal populations at the late disease stages (HD3 and HD4). The gene discussed is CTSD; the disease is Huntington disease.